Here are four key quotes.
On future innovation: “Product innovation continues to be the core of our strategy to drive growth and capture market share and we could not be happier with the momentum we are seeing in 2018. As I shared on our last earnings call, we believe the last year may have been the most important year of product innovation in the history of the company; we anticipate that our impressive new product activity in 2017 will position us to drive above market growth again in 2018.”
On Brainlab: “We continue to target a commercial launch in the second half of 2018. The engineering teams are working closely on the compatibility of K2M spinal systems and instrumentation with Brainlab’s intraoperative imaging guided navigation and imaging platforms.”
On 3-D printing: “3D printing is one of the hottest areas of spine implant innovation and K2M was the first leading spine company to market 3-D printed spinal implant. K2M now offers the most comprehensive portfolio of 3D printed spinal devices.”
On competition: “We are aware of the increasing number of 3-D printed products from competitors. But given our market-leading position, five-plus years of R&D know-how and early commercial entry into the space, we believe we have the engineering and clinical expertise to continue to lead in the new frontier of 3D printed spinal technologies.”
More articles on orthopedic devices:
NuVasive reports 4.6% Q1 revenue growth, $27.1M net loss: 5 key points
Infuse gets new FDA indication for lateral, anterior spinal fusions with PEEK implants
Zimmer Biomet makes new partnership to expand implant access
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
